Evidence map›Paper›PMID 40676077›Full record

ArticleScientific reports2025

Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent.

Sulaiman A Alsalamah, Mohammed Ibrahim Alghonaim, Abeer Mahmoud Mohammad, Ashjan F Khalel, Fatimah S Alqahtani, Tarek M Abdelghany

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Natural Bioactive Compounds fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Analysis of Quality Distinctions of Pumpkin Seed Oil (Molecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ozone-Assisted Green Upgrading ofFoods (Basel, Switzerland) · 2025
    Article
  9. Therapeutic Potential of OzonatedPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sulaiman A AlsalamahDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
Mohammed Ibrahim AlghonaimDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
Abeer Mahmoud MohammadBiology Department, Al-Darb University College, Jazan University, Jazan, Saudi Arabia.ORCID http://orcid.org/0000-0003-3309-048X
Ashjan F KhalelBiology Department, Al-Darb University College, Jazan University, Jazan, Saudi Arabia.ORCID http://orcid.org/0000-0002-4099-7568
Fatimah S AlqahtaniDepartment of Biology, Faculty of Science, University of Bisha, P. O. Box: 551, Bisha, 61922, Saudi Arabia.ORCID http://orcid.org/0009-0008-9818-1538
Tarek M AbdelghanyBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, 11725, Egypt. tabdelghany.201@azhar.edu.eg.ORCID http://orcid.org/0000-0001-6418-5890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pumpkin is a widely recognized plant in the Cucurbitaceae family because of its significance as a pharmaceutical food. Ozonized oils are becoming more popular among researchers and being employed in medical facilities due the continuous search for powerful biomedical medicines that can combat illnesses with controllable negative repercussions. Pumpkin seed oil was ozonized at an average rate of 0 to 8 L/minute. The chemical composition of the oil before and after treatment was characterized using Gas Chromatography-Mass Spectrometry (GC-MS) analysis. Anti- Helicobacter pylori (H. pylori) of both unrefined and ozonized pumpkin oils were detected using agar well diffusion technique. The anti-biofilm was tested at 25, 50 and 75% of MBC. Time killing assay was done to compare the antimicrobial impacts both refined and ozonized oils the various of the antibacterial impact at various time points. Anticancer role versus human prostate cancer cell line (PC-3) cells for oil forms was done using [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] MTT protocol. The change of cell cycles was compared in cancer cells and after treatment by examined oil forms. In vitro alpha glucosidase, alpha amylase and lipase enzymes inhibition was done in both oil samples relative to norms. Both oil forms contained 25 bioactive molecules where ozone exposure altered the molecular diversity with increased the number of classes of molecules in ozonized oil. Additionally, exposure to ozone significantly increased the levels of and n-propyl 9,12-octadecadienoate and 9-Hexadecenoic acid, 9-hexadecenyl ester, (Z, Z)- could be seen with high level in ozonized oil. A slight rise in anti-H. pylori could be seen in ozonized oil which showed bactericidal impact which had been confirmed by time killing assay. The anti-biofilm tested activity reached its maximal level upon using 75% of MBC of ozonized pumpkin seed oil. The ozonized oil had a promising anticancer role towards PC-3 cells through induction of early apoptosis. Exposure of pumpkin oil to the ozone led to improvement in in vitro antidiabetic and anti-obesity roles. These findings support the conclusion that being exposed to pumpkin oil to ozone improves the oil's in vitro impact to pathogenic microbes and diseases that are not transmissible to be applied in preclinical applications in future studies.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsCucurbitaHelicobacter pyloriHypoglycemic AgentsOzonePlant OilsSeedsCell Line, TumorHumansMalePC-3 CellsAnti-Bacterial AgentsAntineoplastic AgentsHypoglycemic AgentsOzonePlant OilsAnticancerAntidiabeticAnti-lipaseApoptosisH. pyloriPumpkin seed oil

Identifiers

PMID40676077
PMCPMC12271415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.